A randomized phase i clinical trial of hydrovax-YFV, a novel inativated yellow fever vaccine
Ended Cooperative Agreement Awarded Last action
- Award ID
- U44AI145791
- Recipient
-
Najit Technologies, Inc. UEI MHB6EFN66MD9
- Awarding agency
-
National Institute of Allergy and Infectious Diseases
National Institutes of Health, Department of Health and Human Services
- Obligated
- $6,111,468
Award facts
- Assistance listing
- 93.855 Allergy and Infectious Diseases Research
- Completion date
- Originally
- Funding
-
- $5,111,816.00 Federal
- $999,652.00 Non-federal
- Place of performance
- Oregon, USA
Award details come from USAspending.gov.
Transactions
| Action | Federal | Non-federal | Date |
|---|---|---|---|
| Amendment | $0 | $0 | |
| Amendment | $825,048 | $0 | |
| Amendment | $997,662 | $0 | |
| Amendment | $997,662 | $0 | |
| Amendment | $0 | $0 | |
| Amendment | $0 | $0 | |
| Amendment | $0 | $0 | |
| Amendment | $0 | $0 | |
| Amendment | $0 | $0 | |
| Amendment | $0 | $0 | |
| Amendment | $999,652 | $0 | |
| Amendment | $999,652 | $999,652 | |
| Amendment | $0 | $0 | |
| Amendment | $0 | $0 | |
| Amendment | $0 | $0 | |
| Original award | $292,140 | $0 |
Show all 16
Quick answers
Who received award U44AI145791?
U44AI145791 was awarded to Najit Technologies, Inc. by National Institute of Allergy and Infectious Diseases (National Institutes of Health) on July 1, 2019.
How much is award U44AI145791 worth?
$6,111,468 has been obligated on U44AI145791: $5,111,816 in federal funding and $999,652 in non-federal funding.
On GovTribe
See this award's full record
- Every transaction and subaward
- The recipient's other awards and teaming partners
- Similar grant awards
- Ask GovTribe AI about this award